Reinduction Ipilimumab Following Acquired Resistance to Combination Ipilimumab and Anti–PD-1 Therapy in Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Reinduction Ipilimumab Following Acquired Resistance to Combination Ipilimumab and Anti-PD-1 Therapy
Eur. J. Cancer 2021 Aug 01;153(xx)213-222, A Hepner, VG Atkinson, J Larkin, RA Burrell, MS Carlino, DB Johnson, L Zimmer, KK Tsai, O Klein, SN Lo, A Haydon, P Bhave, M Lyle, L Pallan, I Pires da Silva, C Gerard, O Michielin, GV Long, AM MenziesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.